Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
56
IRON Quote, Financials, Valuation and Earnings
Last price:
$93.77
Seasonality move
:
11.15%
Day range:
$91.22 - $94.58
52-week range:
$30.82 - $97.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.17x
Volume:
280.4K
Avg. volume:
483.1K
1-year change:
45.5%
Market cap:
$3.5B
Revenue:
--
EPS (TTM):
-$5.36
Analysts' Opinion
-
Consensus RatingDisc Medicine, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $118.17, Disc Medicine, Inc. has an estimated upside of 25.99% from its current price of $93.79.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $91.00 representing 2.98% downside risk from its current price of $93.79.
Fair Value
-
According to the consensus of 12 analysts, Disc Medicine, Inc. has 25.99% upside to fair value with a price target of $118.17 per share.
IRON vs. S&P 500
-
Over the past 5 trading days, Disc Medicine, Inc. has underperformed the S&P 500 by -0.08% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Disc Medicine, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Disc Medicine, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Disc Medicine, Inc. reported revenues of --.
Earnings Growth
-
Disc Medicine, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Disc Medicine, Inc. reported earnings per share of -$1.77.
Enterprise value:
3B
EV / Invested capital:
4.89x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.50x
EV / Free cash flow:
-17.80x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$201K
Return On Assets:
-30.22%
Net Income Margin (TTM):
--
Return On Equity:
-32.82%
Return On Invested Capital:
-31.4%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$509K | -$172K | -$201K | -$11K | -$87K | |
| Operating Income | -$83M | -$124.9M | -$203.6M | -$32.9M | -$67.7M | |
| EBITDA | -$82.5M | -$124.7M | -$203.4M | -$32.8M | -$67.6M | |
| Diluted EPS | -$3.74 | -$3.97 | -$5.36 | -$0.89 | -$1.77 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $154.8M | $104.7M | $374.3M | $493.2M | $627.2M | |
| Total Assets | $155.5M | $106M | $376.5M | $495.1M | $630.5M | |
| Current Liabilities | $12.7M | $1.5M | $14.4M | $25.5M | $26.7M | |
| Total Liabilities | $14.7M | $1.5M | $17.5M | $27.2M | $57.1M | |
| Total Equity | $140.9M | $104.6M | $359M | $468M | $573.4M | |
| Total Debt | $6.6M | -- | $1.6M | $1.7M | $30.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$65.3M | -$84.1M | -$164.7M | -$17.4M | -$47.8M | |
| Cash From Investing | -$98K | -$290.9M | -$172.8M | -$71.1M | $49.5M | |
| Cash From Financing | $380.4M | $197.3M | $285.5M | $426K | $11.6M | |
| Free Cash Flow | -$65.4M | -$84.2M | -$166M | -$17.4M | -$47.8M | |
IRON
Sector
Market Cap
$3.5B
$28.4M
Price % of 52-Week High
96.58%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-11.38%
-1.32%
1-Year Price Total Return
45.5%
-22.19%
Beta (5-Year)
0.866
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$92.67
200-day SMA
Buy
Level
$60.38
Bollinger Bands (100)
Buy
Level
57.99 - 84.27
Chaikin Money Flow
Buy
Level
2.8M
20-day SMA
Buy
Level
$89.90
Relative Strength Index (RSI14)
Buy
Level
63.11
ADX Line
Buy
Level
32.31
Williams %R
Neutral
Level
-32.646
50-day SMA
Buy
Level
$82.31
MACD (12, 26)
Buy
Level
2.93
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
14.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (20.7947)
Buy
CA Score
(Annual)
Level (0.0734)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.4154)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.
Stock Forecast FAQ
In the current month, IRON has received 12 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IRON average analyst price target in the past 3 months is $118.17.
-
Where Will Disc Medicine, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Disc Medicine, Inc. share price will rise to $118.17 per share over the next 12 months.
-
What Do Analysts Say About Disc Medicine, Inc.?
Analysts are divided on their view about Disc Medicine, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Disc Medicine, Inc. is a Sell and believe this share price will drop from its current level to $91.00.
-
What Is Disc Medicine, Inc.'s Price Target?
The price target for Disc Medicine, Inc. over the next 1-year time period is forecast to be $118.17 according to 12 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IRON A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Disc Medicine, Inc. is a Buy. 12 of 12 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of IRON?
You can purchase shares of Disc Medicine, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Disc Medicine, Inc. shares.
-
What Is The Disc Medicine, Inc. Share Price Today?
Disc Medicine, Inc. was last trading at $93.77 per share. This represents the most recent stock quote for Disc Medicine, Inc.. Yesterday, Disc Medicine, Inc. closed at $93.79 per share.
-
How To Buy Disc Medicine, Inc. Stock Online?
In order to purchase Disc Medicine, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get IRON Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IRON
Sector
P/E ratio
--
23.66x
PEG ratio
-0.50x
-0.01x
P/B ratio
6.17x
1.84x
Price / LTM sales
--
1.60x
Growth Metrics
IRON
Sector
Revenue growth
--
4.85%
Earnings growth
-99.39%
11.15%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$1.46
-$0.20
Profitability
IRON
Sector
Profitability FY 2024
-$156K
$3.6M
Return on invested capital
-31.4%
-30.98%
Return on assets
-30.22%
-27.62%
Return on equity
-32.82%
-36.69%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
IRON
Sector
Total cash
$615.9M
$27.2M
Short term investments
$297.4M
$25.7M
Total assets
$496.8M
$79.9M
Long term debt
$30.3M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
44
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
